- Contraceptive gel maker Evofem Biosciences ( OTCQB:EVFM ) has decided to pursue strategic alternatives.
- The company said those alternatives could include a merger, reverse merger, other business combination, sales of assets, licensing, or other strategic transactions
- Evofem ( OTCQB:EVFM ), best known for manufacturing Phexxi, a contraceptive vaginal gel, has hired Joseph Gunnar & Co. as financial advisor .
- Seeking Alpha's Quant Rating has viewed Evofem ( OTCQB:EVFM ) as a strong sell since October 2022.
For further details see:
Evofem Biosciences to pursue strategic alternatives